Effect of the ugt1a3*2 haplotype on pharmacokinetics and pharmacodynamics of atorvastatin in patients with coronary heart disease

23 April 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Heterogeneity of vascular and atherosclerotic risk phenotypes Pharmacogenetics EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)